IRCT20220516054874N14招募中3 期
Evaluation of the effects of Ellagic acid on inflammation and insulin resistance in patients with Type 2 diabetes mellitus and acute coronary syndrome
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes mellitus
- •Patients with a history of myocardial infarction according to the American College of Heart criteria
- •At least 6 months have passed since the diagnosis of diabetes
- •Age more than 18 years old
- •Consent to admission to the study
- •Patients with fasting serum glucose levels greater than or equal to 125 mg/dl
- •Patients with glycosylated hemoglobin blood levels greater than or equal to 6.5%
排除标准
- •Type 1 diabetes
- •Kidney failure and GFR<30
- •Severe liver failure with liver enzymes three times more than normal
- •Chronic inflammatory disease such as lupus
- •Breastfeeding
研究者
相似试验
招募中
2 期
Evaluation of the effects of Ellagic acid on patients with myocardial infarctioIRCT20220516054874N8Mashhad University of Medical Sciences60
招募中
2 期
Evaluation of the effectiveness of ellagic acid on patients with non-alcoholic fatty liver diseasePatients with non-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20180103038199N16Mashhad University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation effect in patients with Major DepressiveMajor depressive episode.Major depressive disorder, single episodeIRCT20141025019669N15Mazandaran University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation in patients with non-alcoholic fatty liver diseaseon alcoholic fatty liver disease.Other specified inflammatory liver diseasesK75.8IRCT20141025019669N21Qazvin University of Medical Sciences44
招募中
3 期
Ellagic acid and type 2 diabetesType 2 diabetes.Type 2 diabetesIRCT20210219050412N1Bagheiat-allah University of Medical Sciences60